BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yin J, Kociolek LK, Same RG, Hsu AJ, Amoah J, Tamma PD. Oral Vancomycin May Be Associated With Earlier Symptom Resolution Than Metronidazole for Hospitalized Children With Nonsevere Clostridiodes difficile Infections. Open Forum Infect Dis 2019;6:ofz492. [PMID: 31950069 DOI: 10.1093/ofid/ofz492] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Stallmach A, Katzer K, Reuken P. [Non-severe Clostridioides difficile Infection: Are the data adequate to give up metronidazole?]. Z Gastroenterol 2020;58:778-84. [PMID: 32785914 DOI: 10.1055/a-1190-5735] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Kociolek LK, Crews JD, Schwenk HT. Recent advances in Clostridioides difficile infection epidemiology, diagnosis and treatment in children. Curr Opin Infect Dis 2021. [PMID: 34232137 DOI: 10.1097/QCO.0000000000000753] [Reference Citation Analysis]
3 Gonzales-Luna AJ, Carlson TJ, Garey KW. Antibiotic Therapies for Clostridioides difficile Infection in Children. J Pediatric Infect Dis Soc 2021;10:S52-7. [PMID: 34791393 DOI: 10.1093/jpids/piab059] [Reference Citation Analysis]
4 Marcela K, de Meij GT, Fidelma F, Richard DJ, Mark WH, Ed KJ. How to: Clostridioides difficile infection in children. Clinical Microbiology and Infection 2022. [DOI: 10.1016/j.cmi.2022.03.001] [Reference Citation Analysis]
5 Adams DJ, Barone JB, Nylund CM. Community-Associated Clostridioides difficile Infection in Children: A Review of Recent Literature. J Pediatric Infect Dis Soc 2021;10:S22-6. [PMID: 34791398 DOI: 10.1093/jpids/piab064] [Reference Citation Analysis]
6 Stultz JS, Hopp J, Orndahl CM, Omecene NE, Pakyz AL. Changes in Metronidazole and Vancomycin Utilization for Nonsevere Clostridioides difficile Infection Among Institutions Caring for Children. Pediatr Infect Dis J 2021;40:634-6. [PMID: 33657601 DOI: 10.1097/INF.0000000000003117] [Reference Citation Analysis]
7 Skinner AM, Scardina T, Kociolek LK. Fidaxomicin for the treatment of Clostridioides difficile in children. Future Microbiol 2020;15:967-79. [PMID: 32715754 DOI: 10.2217/fmb-2020-0104] [Reference Citation Analysis]
8 Sattler MM, Crews JD. Challenges in the Diagnosis and Management of Recurrent and Severe Clostridioides difficile Infection in Children. J Pediatric Infect Dis Soc 2021;10:S27-33. [PMID: 34791399 DOI: 10.1093/jpids/piab079] [Reference Citation Analysis]